Hester Biosciences

Hester Biosciences OCF Margin

The Operating Cash Flow Margin of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026 is 17.90 %. In the previous year, Operating Cash Flow Margin was 20.74 % — a change of -13.68% (lower).

OCF Margin

17.90 %

YoY

-13.68%

Last updated:

Operating Cash Flow Margin of Hester Biosciences is 2026 17.90 % . Operating Cash Flow Margin of Hester Biosciences was 2025 20.74 % . It decreases by -13.68% lower compared to the previous year.

The Hester Biosciences OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
27.07 INR
Jan 1, 2020
20.89 INR
Jan 1, 2021
27.09 INR
Jan 1, 2022
3.75 INR
Jan 1, 2023
8.87 INR
Jan 1, 2024
15.81 INR
Jan 1, 2025
20.74 INR
Jan 1, 2026
17.90 INR
The Hester Biosciences OCF Margin history
YEAROCF MarginYoY
17.90 %-13.68%
20.74 %+31.20%
15.81 %+78.23%
8.87 %+136.60%
3.75 %-86.16%
27.09 %+29.63%
20.89 %-22.83%
27.07 %-3.21%
27.97 %-1.04%
28.27 %+46.67%
19.27 %-26.67%
26.28 %+92.16%
13.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

Operating Cash Flow Margin of Hester Biosciences is 17.90 % in 2026.

Operating Cash Flow Margin of Hester Biosciences changed from 20.74 % to 17.90 %, representing a -13.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Hester Biosciences with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Hester Biosciences

All Key Metrics — Hester Biosciences